Our previous and current results point to a dual mechanism by which SIRT1 overexpression contributes to cholestasis disease progression: (1) increased BA-mediated hepatocellular cell death,27 coupled with (2) increased inflammation mediated by the hyperactivation of macrophages overall aggravating cellular damage. The gene discussed is SIRT1; the disease is cholestasis.